文献速递妇科

Fitbit体力活动监测器在子宫内膜癌幸存者中的可接受性与可行性

Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors.
PubMed 文献 · Gynecol Oncol · 2018-01-01

研究纳入30例子宫内膜癌幸存者佩戴腕式Fitbit Alta™ 30天,25例完成研究。参与者中位佩戴天数占可能天数的93%,中位日步数5325(IQR 3761-8753),技术接受度均分2.8±0.5(满分4.0)。Fitbit可接受性良好,但自报体力活动与记录步数无相关性(CCC=0.00,p=0.99)。

要点

  • 子宫内膜癌幸存者佩戴Fitbit中位天数占可能天数的93%,可接受性良好。
  • 中位日步数5325(IQR 3761-8753),提示该人群活动不足。
  • 自报体力活动(GLTEQ指数)与Fitbit步数无相关性(CCC=0.00,p=0.99)。

核心结论

  • Fitbit在该样本中可接受性良好;自报体力活动与记录步数无关联;体力活动数据提示该人群活动不足。

研究设计与样本

  • 研究为可接受性与有效性评估,纳入30例子宫内膜癌幸存者,佩戴腕式Fitbit Alta™ 30天,25例完成研究。

主要发现

  • 参与者平均年龄62±9岁,平均BMI 32±9 kg·m-2。
  • 自报种族/族裔为36%西班牙裔、36%非西班牙裔白人、16%非西班牙裔黑人、12%亚裔。
  • 参与者佩戴Fitbit中位天数占可能天数的93%;中位日步数5325(IQR 3761-8753)。
  • 技术接受度均分2.8±0.5(满分4.0);年轻(<65岁)和在职参与者更可能达到每日至少6000步(p<0.05)。
  • 步数与GLTEQ指数无相关性(CCC=0.00,p=0.99);多数自由回答反映积极体验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70% obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. METHODS: Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. RESULTS: Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m-2. Self-identified race/ethnicity was 36% Hispanic, 36% non-Hispanic white, 16% non-Hispanic black and 12% Asian. Participants wore the Fitbits a median of 93% of possible days. Median daily Fitbit step count was 5325 (IQR: 3761-8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. CONCLUSIONS: The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rossi A, Frechette L, Miller D, et al. Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors. Gynecol Oncol. 2018. PMID: 29692337. doi:10.1016/j.ygyno.2018.04.560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。